Randomised clinical trials with clinician-preferred treatment
The LancetPublished 1 January 1991
Edward L. Korn
Citations57
SJR quartileQ1
SJR score12.11
SNIP22.72
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The standard design for randomised clinical trials may be inappropriate when a clinician believes that one of the treatments being tested is superior for the patient, or when the clinician has a preference for one ofthe treatments.
Abstract
The standard design for randomised clinical trials may be inappropriate when the clinician believes that one of the treatments being tested is superior for the patient, or when the clinician has a preference for one of the treatments. For such instances the suggestion is that the patient is randomly allocated to treatment only when there is clinical disagreement about treatment of choice for that patient, and then the patient is assigned to a clinician who had thought that the regimen allocated is the one most appropriate for that patient.
Keywords
MedicineEconomics, Econometrics and Finance
Journal of Educational PsychologyEstimating causal effects of treatments in randomized and nonrandomized studies.
9,471 Citations1974Donald B. Rubin
British Journal of CancerDesign and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
8,392 Citations1977Richard Peto, M. C. Pike +8 more
Efficient methods of analysis of randomized clinical trials in which the authors wish to compare the duration of survival among different groups of patients are described.
British Journal of CancerDesign and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design
2,312 Citations1976Richard Peto, Malcolm C. Pike +8 more
This report is the first simple account yet published for non-statistical physicians of how to analyse efficiently data from clinical trials of survival duration, and it may be preferable to use these statistical methods to study time to local recurrence of tumour, or toStudy time to detectable metastatic spread, in addition to studying total survival.
BiometricsSequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial
2,302 Citations1975Stuart Pocock, Richard Simon
A new general procedure for treatment assignment is described which concentrates on minimizing imbalance in the distributions of treatment numbers within the levels of each individual prognostic factor.
PEDIATRICSExtracorporeal Membrane Oxygenation and Conventional Medical Therapy in Neonates With Persistent Pulmonary Hypertension of the Newborn: A Prospective Randomized Study
493 Citations1989P. Pearl O’Rourke, Robert K. Crone +5 more
Thirty-nine newborn infants with severe persistent pulmonary hypertension and respiratory failure who met criteria for 85% likelihood of dying were enrolled in a randomized trial in which extracorporeal membrane oxygenation (ECMO) therapy was compared with conventional medical therapy (CMT).
New England Journal of MedicinePhysicians’ Reasons for Not Entering Eligible Patients in a Randomized Clinical Trial of Surgery for Breast Cancer
412 Citations1984Kathryn M. Taylor, Richard G. Margolese +1 more
Investigation into the behavioral aspects of the investigator-patient relationship is particularly pressing, since fear of change in this relationship was the most common reason given for not entering eligible patients in the trial.
New England Journal of MedicineThe Ethics of the Randomized Clinical Trial
193 Citations1982Arthur Schafer
Some of the major ethical problems posed by the randomized clinical trial are distinguished, to set out some of the principal considerations.
Journal of Clinical OncologyHow expert physicians would wish to be treated if they had genitourinary cancer.
163 Citations1988Michael J. Moore, Brian O’Sullivan +1 more
This physician surrogate method is a valuable tool in assessment of the degree of consensus amongst expert physicians and in the determination of whether new clinical trials address important areas of controversy.
New England Journal of MedicinePatients’ Preferences in Randomized Clinical Trials
143 Citations1984Marcia Angell
The results of a questionnaire study of why participating physicians entered so few of their eligible patients into the NSABP trial found a low rate of accrual.
New England Journal of MedicineRandomization Designs in Comparative Clinical Trials
112 Citations1984Susan S. Ellenberg
A modification of this randomization procedure, the "randomized-consent design," has recently been introduced into the practice of clinical trials to eliminate what many physicians feel to be a most uncomfortable and difficult aspect of randomized clinical trials: having to obtain the patient's consent.
British Journal of CancerThe use of expert surrogates to evaluate clinical trials in non-small cell lung cancer
83 Citations1987W.J. Mackillop, G Ward +1 more
It is concluded that some patients with non-oat cell lung cancer currently receive experimental therapies with high risk/benefits ratios which experts in the field would not accept for themselves.
Clinical Pharmacology & TherapeuticsEthical considerations in clinical trials
80 Citations1979Robert J. Levine, Karen Lebacqz
It is concluded that problems of justice arise not only of the vulnerability of patients in VA hospitals hut also of the loss of the physician‐patient relationship in an RCT, and the values and preferences of the subjects should be taken into account in determining what information might be material.
BMJEthics of clinical research: lessons for the future.
45 Citations1989Michael Baum, K J Zilkha +1 more
The Bulletin of the Institute of Medical Ethics published an anonymous article by an aggrieved patient complaining that she was entered into two clinical trials without informed consent, followed by a discussion of the ethical issues of consent in randomised trials.